Citizen Petition from American College of Obstetricians and Gynecologists

A registered nurse who performs limited ultrasounds argues that removing the REMS for abortion pills would endanger women's health by allowing for abortions without proper pregnancy dating and confirmation. The commenter contends that the medical community is prioritizing political views over patient safety and that the abortion industry prioritizes profit over health.

Arkansas Right To Life, an advocacy organization, opposes the citizen petition by the American College of Obstetricians and Gynecologists. They argue that the FDA should maintain strict Risk Evaluation and Mitigation Strategies (REMS) for mifepristone, including in-person physician visits and ultrasound requirements, to ensure safety and prevent unauthorized use.

A medical worker in a women's health facility argues that patients who use medication to induce an abortion without in-person medical supervision face significant health risks and ineffective results. The commenter advocates for regulated, in-person medical care including ultrasounds and pregnancy confirmation.

The Advancing American Freedom Foundation opposes the ACOG petition, arguing that the FDA should not lift Risk Evaluation and Mitigation Strategies (REMS) for mifepristone. They urge the FDA to reinstate stricter regulations, including in-person physician consultations, citing concerns over the drug's safety and the potential for serious adverse events.